bendamustine hydrochloride has been researched along with Agranulocytosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colomo, L; Diez-Feijóo, R; Fernández-Rodríguez, C; Ferrer, A; Flores, S; Raya, C; Rodríguez-Sevilla, JJ; Salar, A | 1 |
1 other study(ies) available for bendamustine hydrochloride and Agranulocytosis
| Article | Year |
|---|---|
Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine.
Topics: Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Dose-Response Relationship, Drug; Humans; Immunoglobulins, Intravenous; Male; Rituximab; Treatment Outcome; Waldenstrom Macroglobulinemia | 2021 |